Dr. Uta Griesenbach

Biography

Uta Griesenbach is a Professor of Molecular Medicine at the National Heart & Lung Institute, Imperial College London. She joined the Gene Therapy Group at Imperial College in 1997 after graduating from the University of Bonn in Germany. Uta completed her PhD at the Hospital for Sick Children in Toronto, Canada, under the supervision of Lap-Chee Tsui. She served as the President of the British Society of Gene and Cell Therapy from 2017 to 2021 and is a Non-Executive Board Member of the Cell and Gene Therapy Catapult. Uta is actively involved in overseeing research related to gene therapy in the UK, including her role as a panel member for the MRC-Developmental Pathway Funding Scheme and on the Biomedical Catalyst Major Awards Committee. Her interests in teaching include directing the MSc program in Genes, Drugs, and Stem Cells and supervising a range of research projects. Uta's research focuses on the development of novel gene and cell therapy-based treatments for cystic fibrosis, inflammatory lung diseases, and hemophilia. She has contributed significantly to clinical trials, particularly in gene therapy for cystic fibrosis, and is a co-investigator in ongoing trials. Uta has published over 90 peer-reviewed papers and holds patents related to viral gene transfer. Her collaborative work with institutes such as UCL and King's College London further strengthens the field of Advanced Therapeutic Medicinal Products in the UK.

Research Interests